Kinase inhibitor drugs

A comprehensive resource on case studies of marketed kinase drugs and promising drug trialsSince the discovery of protein kinase activity in 1954, the field of protein kinase drug discovery has advanced dramatically. With the ongoing clinical success of the Bcr-Abl kinase inhibitor Gleevec in the tr...

Descripción completa

Detalles Bibliográficos
Formato: Printed Book
Lenguaje:Undetermined
Publicado: New Jersey.
Materias:
Therapeutic use, Protein Kinase Inhibitors, Protein kinases, Pharmacology, Antineoplastic agents, Neoplasms, Inhibitors, Metabolism, Drug therapy, Protein Kinases, Drug Discovery, Antineoplastic Agent

University of Kerala

Detalle de Existencias desde University of Kerala
Número de Clasificación: P-,9B E6.1(CR),F3.1
Copia CR Estatus de actividad no disponible
Copia Estatus de actividad no disponible

Ejemplares similares